Final answer:
Buprenorphine (Schedule III) and naltrexone (Schedule III or IV depending on the form) are the main drug products used for maintenance and detoxification therapy in Narcotic Treatment Programs. They help to reduce cravings, withdrawal symptoms, and block the effects of opioids.
Step-by-step explanation:
The main drug products from Schedule III, IV or V commonly used for maintenance and detoxification treatment in Narcotic Treatment Programs are buprenorphine (Schedule III) and naltrexone (Schedule III for the injectable form and Schedule IV for the oral form). Methadone while commonly used in treatment, is actually a Schedule II substance due to its higher potential for abuse and is not part of this list. Buprenorphine is used to help reduce cravings and withdrawal symptoms without producing a significant high, making it effective for long-term therapy.
Naltrexone on the other hand, is a narcotic antagonist that blocks the effects of opioids entirely, supporting individuals in maintaining abstinence. Neither buprenorphine nor naltrexone produces euphoria when taken as prescribed which helps to prevent misuse.